Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
inRange: Toujeo vs Tresiba in Type 1 Diabetes
NCT04075513Phase 4Completed
- Sponsor
- Sanofi
- Start
- Oct 2019
- Primary completion
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 7
01
Overview
A Phase 4 trial of insulin glargine in type 1 diabetes mellitus (T1D), sponsored by Sanofi. Started Oct 2019; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04075513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04075513.